Òtù Ahụ Ike Ụwa (WHO) mara ọkwa taa na GlaxoSmithKline (GSK) ga-emeghachi nkwa ya inye onyinye ọgwụ na-egbu egbu albendazole ruo mgbe mkpochapụ zuru ụwa ọnụ nke lymphatic filariasis dị ka nsogbu ahụike ọha. Na mgbakwunye, site na 2025, a ga-enye mbadamba 200 nde kwa afọ maka ọgwụgwọ STH, na 2025, mbadamba 5 nde kwa afọ maka ọgwụgwọ cystic echinococcosis.
Nkwuputa ọhụrụ a na-ewuli elu n'afọ 23 nke ụlọ ọrụ ahụ iji lụso ọrịa atọ a na-eleghara anya nke Tropical Diseases (NTD) na-akpagbu ụfọdụ obodo ndị kasị daa ogbenye n'ụwa.
Nkwenye ndị a bụ naanị akụkụ nke nnukwu nkwa GSK mere taa na Mgbakọ Ọrịa ịba na nke a na-eleghara anya na Kigali, ebe ha kwuputara ntinye ego £ 1 ijeri n'ime afọ 10 iji kwalite ọganihu na ọrịa na-efe efe. - mba nke ego. Mbipụta ndị nchụ nta akụkọ).
Nchọpụta ahụ ga-elekwasị anya na ọgwụ ọhụrụ na-emepụta ọgwụ na ọgwụ mgbochi iji gbochie na ịgwọ ọrịa ịba, ụkwara nta, HIV (site na ViiV Healthcare) na ọrịa okpomọkụ na-eleghara anya, ma na-eleba anya nguzogide mgbochi ọrịa, nke na-aga n'ihu na-emetụta ndị mmadụ na-adịghị ike ma na-akpata ọtụtụ ọnwụ. . Ibu ọrịa n'ọtụtụ mba ndị na-akpata obere ego karịrị 60%.